Health Care Current library

This weekly series explores breaking news and developments in the US health care industry; examines key issues facing life sciences and health care companies; and provides updates and insights on policy, regulatory, and legislative changes.


Health Care Blog

Read the Center for Health Solutions blog, sharing timely insights, research, and forward thinking for the life sciences and health care industry.


Research & Development

Life Sciences

The pressures of ever-looming patent cliffs and demands for less expensive drugs and medical devices are making product innovation an imperative for Life Sciences companies. While the rewards may be considerable, potential hurdles to Research & Development —among them, increased regulatory scrutiny, pricing issues, skyrocketing development costs, technological change, intellectual property threats, globalization, and fragmented markets--can stymie Life Sciences companies in their efforts to use disruptive innovation to maintain or grow market share.

Explore Content

The professionals in Deloitte’s Life Sciences Research & Development practice understand the unique challenges that are confronting today’s Research & Development organizations. Whether it’s an emerging player seeking an effective growth strategy or an established organization looking to adapt to the changing marketplace, we help our clients transform the value Research & Development brings to their organization and the marketplace. Our approaches are pragmatic and realistic, and span the continuum from new Research & Development operating models through portfolio management, data analytics, Research & Development IT transformation, and regulatory and safety considerations.

When executing an open innovation model, cooperation is key to competition

Biopharma companies’ reliance on a traditional, closed R&D model might stifle true innovation. However, companies that adopt a cooperative, open innovation framework are likely to spur product development, speed time to market, reduce costs, and increase competitiveness.

Measuring the return from pharmaceutical innovation: Turning a corner?

The fifth annual study of the pharmaceutical industry’s performance in generating a return from its significant investment in R&D. The report allows industry leaders to understand the drivers of successful R&D strategies that are tangible and, most importantly, actionable.

More topics


About the Deloitte Center for Health Solutions

About the Deloitte Center for Health Solutions: The source for health care insights.


ConvergeHEALTH by Deloitte

ConvergeHEALTH brings together analytics platforms and data models, enabling health care and life sciences organizations to answer the “hard questions.”

Dan Ressler

R&D Practice Leader | Life Sciences

Greg Reh

US life sciences sector leader

Neil Lesser

Principal | Life Sciences | Monitor Deloitte

Dbriefs Webcast

Health Sciences

Anticipating tomorrow's complex issues and new strategies is a challenge. Take the lead with Dbriefs—live webcasts that give you valuable insights on important developments affecting your business. Dbriefs offers live webcasts featuring practical knowledge from Deloitte specialists.